Natixis Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
|
|||||
|
2025
Q1 | $1.56M | Buy |
|
|||||
|
2024
Q4 | $2.34M | Buy |
|
|||||
|
2024
Q3 | $2.27M | Buy |
|
|||||
|
2024
Q2 | $1.46M | Buy |
|
|||||
|
2024
Q1 | $1.28M | Buy |
|
|||||
|
2023
Q4 | $908K | Sell |
|
|||||
|
2023
Q3 | $762K | Buy |
|
|||||
|
2023
Q2 | $367K | Buy |
|
|||||
|
2023
Q1 | $325K | Buy |
|
|||||
|
2022
Q4 | $215K | Sell |
|
|||||
|
2022
Q3 | $233K | Sell |
|
|||||
|
2022
Q2 | $222K | Buy |
|